EAPC Premium Access

Efficacy and safety of PCSK9 inhibitors in lipid control in a follow-up at 6 months.

Congress Session

About the speaker

Doctor Alfredo Chauca Tapia

University Hospital de Girona Dr. Josep Trueta, Girona (Spain)
0 follower

9 more presentations in this session

Lipids - Poster discussant:

Thumbnail

Improvement of lipid profile post cardiac rehabilitation according to the patient's level of risk in a tertiary hospital

Speaker: Doctor A. Chauca Tapia (Girona, ES)

Thumbnail

Efficacy of the PCSK9 inhibitors evolocumab/alirozumab in the reduction of LDL and Lp (a) in patients with familial hypercholesterolemia/manifest atherosclerosis in a real world setting

Speaker: Mr M. Poudel (Bielefeld, DE)

Thumbnail

Anti-PCSK9 in everyday clinical practice

Speaker: Doctor R. Cadenas Chamorro (Madrid, ES)

Thumbnail

Evaluation of LDL cholesterol level in patients with coronary artery disese after cardiac rehabilitation

Speaker: Doctor N. Mouine (Rabat, MA)

Thumbnail

Access the full session

Poster Session 1 - Lipids

Speakers: Doctor A. Chauca Tapia, Doctor A. Chauca Tapia, Mr M. Poudel, Doctor R. Cadenas Chamorro, Doctor N. Mouine
Thumbnail

About the event

Image

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk